Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark E. Saad currently holds 19,129 shares of Axsome Therapeutics, Inc. (AXSM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark E. Saad has been a net seller of AXSM stock. They have purchased $420.6K and sold $2.1M worth of shares.
Mark E. Saad's most recent insider trade was on Sep 5, 2025, when they sold 9,127 shares at $9.00 per share.
Mark E. Saad serves as Executive at Axsome Therapeutics, Inc. (AXSM). They have executed 74 insider transactions totaling $2.6M over their tenure at the company.
Mark E. Saad holds the position of Executive at Axsome Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Mark E. Saad has shown a selling trading pattern, with $420.6K in total purchases and $2.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark E. Saad was on Sep 5, 2025, when they sold $1.1M worth of AXSM shares. This transaction involved 9,127 shares at $125.07 per share.
Mark E. Saad currently owns 19,129 shares of Axsome Therapeutics, Inc. (AXSM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark E. Saad's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark E. Saad has 74 Form 4 filings on record as an insider at Axsome Therapeutics, Inc..
Set alerts for Mark E. Saad and 40,000+ other insiders.